Use of RCMP to Predict Treatment Outcomes of Maxillomandibular Advancement Surgery for OSA
Primary Purpose
Obstructive Sleep Apnea, Maxillomandibular Advancement Surgery
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
RCMP titration
Sponsored by
About this trial
This is an interventional other trial for Obstructive Sleep Apnea
Eligibility Criteria
Inclusion Criteria:
- Moderate to severe OSA (AHI>15 )
- Age 18 years or older
- BMI<40,
- Baseline polysomnogram completed within the last 12 months with no significant weight changes (<10 lbs. weight fluctuation).
- The baseline sleep study must be diagnostic with adequate sample
Exclusion Criteria:
- BMI ≥ 40
- pregnancy
- Central sleep apnea (CSA) - 5 or more central apneas per hour
- Psychoactive medications that influence sleep
- Chronic opioid use
- Other sleep disorders
- Active temporomandibular joint (TMJ) Disorders
- Fibromyalgia with significant facial pain
- Inability to protrude the mandible beyond 5 mm
- Inability to follow-up after surgery
- Uncontrolled psychiatric disorders
- Dental disorders including loose teeth and periodontal disease
Sites / Locations
- Michigan Medicine Oral and Maxillofacial SurgeryRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
RCMP titration
Arm Description
Remotely Controlled Mandibular Positioner
Outcomes
Primary Outcome Measures
Change in Apnea-hypopnea indexes (AHI) before and after surgery
A fifty percent or greater reduction in AHI with a AHI value less than 15 after surgery is considered a successful MMA surgery.
Secondary Outcome Measures
Full Information
NCT ID
NCT03929549
First Posted
April 24, 2019
Last Updated
October 11, 2022
Sponsor
University of Michigan
1. Study Identification
Unique Protocol Identification Number
NCT03929549
Brief Title
Use of RCMP to Predict Treatment Outcomes of Maxillomandibular Advancement Surgery for OSA
Official Title
Use of Remotely Controlled Mandibular Positioner (RCMP) to Predict Treatment Outcomes of Maxillomandibular Advancement Surgery for Obstructive Sleep Apnea (OSA).
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
August 12, 2019 (Actual)
Primary Completion Date
October 2024 (Anticipated)
Study Completion Date
October 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Michigan
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
5. Study Description
Brief Summary
Maxillomandibular advancement (MMA) surgery, one of the most successful surgical procedures for the treatment of obstructive sleep apnea (OSA), is predominantly used to manage patients with moderate to severe OSA. However, limiting factors include incomplete response in some cases, unfavorable facial changes as a result of large advancements, and risk of malocclusion or malunion.
This study will be done to determine predictors of success with MMA surgery in patients with moderate to severe OSA. Studies have already shown the value of a remote controlled mandibular positioner (RCMP) device to identify the correct level of therapeutic protrusion needed with oral appliance therapy. Moreover, some patients experience a dose dependent improvement in sleep parameters based on the degree of protrusion during the titration study. Use of RCMP as a means to identify potential candidates for MMA, may help customize treatment options for patients with OSA by providing predictive value.
Detailed Description
The use of a remotely controlled mandibular protrusion (RCMP) device allows for customization of treatment by titrating the extent of mandibular protrusion during a polysomnogram. Use of the RCMP device has a high degree of positive and negative predictive value in determining the effectiveness and degree (effective target protrusive position) of mandibular advancement need with oral appliance therapy (Remmers, 2013). Preliminary data from 4 patients (Hoekena 2006) indicates that patients with a significant response to oral appliance therapy (>50% reduction in AHI) may have a better response to MMA. This study will determine the efficacy of MMA in patients with moderate to severe OSA, and determine if the RCMP titration can predict success or failure with MMA for treatment of OSA.
Patients will undergo detailed history and physical examination by Oral & Maxillofacial Surgery. Those patients found to be potential candidates for jaw advancement (MMA) surgery will be recruited to enroll in the study. Once consented and enrolled, study participants will undergo a titration study using a remote controlled mandibular positioner (RCMP titration study) to evaluate changes in polysomnographic parameters (i.e. Apnea-hypopnea index and oxygen saturation) with mandibular protrusion. Patients will then undergo maxillomandibular advancement surgery (MMA surgery). During MMA surgery, a standard 10 mm advancement of the upper and lower jaw is performed. Slight modifications may be made to the degree of advancement in order to achieve acceptable facial esthetics. Data from the RCMP titration study will not affect how the MMA surgery is performed. After surgery, participants will have a follow-up polysomnogram four to eight months post-operatively to assess for treatment response and compared this to the predicted response based on the RCMP titration study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obstructive Sleep Apnea, Maxillomandibular Advancement Surgery
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
RCMP titration
Arm Type
Experimental
Arm Description
Remotely Controlled Mandibular Positioner
Intervention Type
Device
Intervention Name(s)
RCMP titration
Other Intervention Name(s)
Remotely Controlled Mandibular Positioner
Intervention Description
An overnight titration polysomnogram with gradual mandibular protrusion and assessment of polysomnographic parameters (i.e. AHI, oxygen saturation, etc.) at various magnitudes of protrusion.
Primary Outcome Measure Information:
Title
Change in Apnea-hypopnea indexes (AHI) before and after surgery
Description
A fifty percent or greater reduction in AHI with a AHI value less than 15 after surgery is considered a successful MMA surgery.
Time Frame
baseline (pre-operative), post surgery (6 months)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Moderate to severe OSA (AHI>15 )
Age 18 years or older
BMI<40,
Baseline polysomnogram completed within the last 12 months with no significant weight changes (<10 lbs. weight fluctuation).
The baseline sleep study must be diagnostic with adequate sample
Exclusion Criteria:
BMI ≥ 40
pregnancy
Central sleep apnea (CSA) - 5 or more central apneas per hour
Psychoactive medications that influence sleep
Chronic opioid use
Other sleep disorders
Active temporomandibular joint (TMJ) Disorders
Fibromyalgia with significant facial pain
Inability to protrude the mandible beyond 5 mm
Inability to follow-up after surgery
Uncontrolled psychiatric disorders
Dental disorders including loose teeth and periodontal disease
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jennifer Lay-Luskin
Phone
734-763-5963
Email
jalay@med.umich.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sharon Aronovich, DMD
Organizational Affiliation
University of Michigan
Official's Role
Principal Investigator
Facility Information:
Facility Name
Michigan Medicine Oral and Maxillofacial Surgery
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48109
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer a Lay-Luskin, MPhil
Phone
734-936-5950
Email
jalay@med.umich.edu
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
We will share deidentified individual patient data which supports the results reported in research publications. The data will be published as supplemental files with the original publication.
IPD Sharing Time Frame
Upon publication (Deidentified individual patient data may be published as supplemental files to an original research paper)
IPD Sharing Access Criteria
Deidentified individual patient data shared with a published paper will be published as supplemental files with the original publication
Learn more about this trial
Use of RCMP to Predict Treatment Outcomes of Maxillomandibular Advancement Surgery for OSA
We'll reach out to this number within 24 hrs